Post PCI atrial fibrillation

References

• Benjamin E. J., Wolf P. A., D'Agostino R. B., Silbershatz H., Kannel W. B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946–52
   PubMed Web of Science ®Google Scholar
• Chugh S. S., Blackshear J. L., Shen W. K., Hammill S. C., Gersh B. J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001; 37: 371–8
   PubMed Web of Science ®Google Scholar
• Dorian P., Jung W., Newman D., et al. The impairment of health‐related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303–9
   PubMed Web of Science ®Google Scholar
• Crenshaw B. S., Ward S. R., Granger C. B., Stebbins A. L., Topol E. J., Califf R. M. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO‐I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 406–13
   PubMed Web of Science ®Google Scholar
• Wong C. K., White H. D., Wilcox R. G., et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO‐III experience. Am Heart J 2000; 140: 878–85
   PubMed Web of Science ®Google Scholar
• Pizzetti F., Turazza F. M., Franzosi M. G., , GISSI‐3 Investigators, et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI‐3 data. Heart 2001; 86: 527–32
   PubMed Web of Science ®Google Scholar
• Eldar M., Canetti M., Rotstein Z., et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 1998; 97: 965–70
   PubMed Web of Science ®Google Scholar
• Lehto M., Snapinn S., Dickstein K., Swedberg K., Nieminen M. S., OPTIMAAL investigators. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 2005; 26: 350–6
   PubMed Web of Science ®Google Scholar
• Pedersen O. D., Bagger H., Kober L., Torp‐Pedersen C. The occurrence and prognostic significance of atrial fibrillation/‐flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J 1999; 20: 748–54
   PubMed Web of Science ®Google Scholar
• Asanin M., Perunicic J., Mrdovic I., et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2005; 7: 671–6
   PubMed Web of Science ®Google Scholar
• Sakata K., Kurihara H., Iwamori K., et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol 1997; 80: 1522–7
   PubMed Web of Science ®Google Scholar
• Sugiura T., Iwasaka T., Takahashi N., et al. Factors associated with atrial fibrillation in Q wave anterior myocardial infarction. Am Heart J 1991; 121: 1409–12
   PubMed Web of Science ®Google Scholar
• Hod H., Lew A. S., Keltai M., et al. Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation 1987; 75: 146–50
   PubMed Web of Science ®Google Scholar
• Kyriakidis M., Barbetseas J., Antonopoulos A., Skouros C., Tentolouris C., Toutouzas P. Early atrial arrhythmias in acute myocardial infarction. Role of the sinus node artery. Chest 1992; 101: 944–7
   PubMed Web of Science ®Google Scholar
• Al‐Shanafey S., Dodds L., Langille D., Ali I., Henteleff H., Dobson R. Nodal vessels disease as a risk factor for atrial fibrillation after coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2001; 19: 821–6
   PubMed Web of Science ®Google Scholar
• Tjandrawidjaja M. C., Fu Y., Kim D. H., Burton J. R., Lindholm L., Armstrong P. W., CAPTORS II Investigators. Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. J Electrocardiol 2005; 38: 271–8
   PubMed Web of Science ®Google Scholar
• Mehta R. H., Dabbous O. H., Granger C. B., , GRACE Investigators, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003; 92: 1031–6
   PubMed Web of Science ®Google Scholar
• Al‐Khatib S. M., Pieper K. S., Lee K. L., et al. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST‐segment elevation: results from the PURSUIT trial. Am J Cardiol 2001; 88: 76–9
   Web of Science ®Google Scholar
• Kassem‐Moussa H., Mahaffey K. W., Graffagnino C., , SYMPHONY and 2nd SYMPHONY Investigators, et al. Incidence and characteristics of stroke during 90‐day follow‐up in patients stabilized after an acute coronary syndrome. Am Heart J 2004; 148: 439–46
   PubMed Web of Science ®Google Scholar
• Grines C. L., Browne K. F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673–9
   PubMed Web of Science ®Google Scholar
• Zijlstra F., de Boer M. J., Hoorntje J. C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–4
   PubMed Web of Science ®Google Scholar
• Kinjo K., Sato H., Sato H., et al. Prognostic significance of atrial fibrillation/ atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92: 1150–4
   PubMed Web of Science ®Google Scholar
• Goldberg R. J., Yarzebski J., Lessard D., Wu J., Gore J. M. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community‐wide perspective. Am Heart J 2002; 143: 519–27
   PubMed Web of Science ®Google Scholar
• Pedersen O. D., Abildstrom S. Z., Ottesen M. M., et al. TRACE Study Investigators. Increased risk of sudden and non‐sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 2006; 27: 290–5
   PubMed Web of Science ®Google Scholar
• Laurent G., Zeller M., Dentan G., et al. Prognostic impact of new onset atrial fibrillation in acute non‐ST elevation myocardial infarction data from the RICO survey. Heart 2005; 91: 369–70
   PubMedGoogle Scholar
• Mehta R. H., Harjai K. J., Grines L., et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 2004; 43: 1765–72
   PubMed Web of Science ®Google Scholar
• El‐Omar M. M., Dangas G., Mehran R., et al. Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. Am J Cardiol 2003; 91: 232–4
   PubMed Web of Science ®Google Scholar
• Cheng C. I., Yeh K. H., Chang H. W., et al. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 2004; 126: 47–53
   PubMed Web of Science ®Google Scholar
• Schoonderwoerd B. A., Van Gelder I. C., Crijns H. J. Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: 224–8
   PubMed Web of Science ®Google Scholar
• Bunc M., Starc R., Podbregar M., Brucan A. Conversion of atrial fibrillation into a sinus rhythm by coronary angioplasty in a patient with acute myocardial infarction. Eur J Emerg Med 2001; 8: 141–5
   PubMedGoogle Scholar
• Avezum A., Makdisse M., Spencer F., et al. GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149: 67–73
   PubMed Web of Science ®Google Scholar
• Sugiura T., Nakamura S., Kudo Y., Okumiya T., Yamasaki F., Iwasaka T. Clinical factors associated with persistent pericardial effusion after successful primary coronary angioplasty. Chest 2005; 128: 798–803
   PubMed Web of Science ®Google Scholar
• Aboufakher R., Riba A., Jani S. M., et al. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 2005; 150: 455–8
   PubMed Web of Science ®Google Scholar
• Roe M. T., Mahaffey K. W., Kilaru R., et al. Creatine kinase‐MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J 2004; 25: 313–21
   PubMed Web of Science ®Google Scholar
• Dilaveris P. E., Gialafos E. J., Sideris S. K., et al. Simple Electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733–8
   PubMed Web of Science ®Google Scholar
• Gorenek B., Kudaiberdieva G., Cavusoglu Y., et al. Immediate recurrence of atrial fibrillation after internal cardioversion: importance of right atrial conduction variations. J Electrocardiol 2002; 35: 313–20
   PubMed Web of Science ®Google Scholar
• Gialafos J. E. P‐wave dispersion. Eur Heart J 1999; 20: 317
   PubMed Web of Science ®Google Scholar
• Tanigawa M., Fukatani M., Konoe A., et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sinus sick node syndrome. J Am Coll Cardiol 1991; 17: 403–8
   PubMed Web of Science ®Google Scholar
• Centurion O. A., Isomoto S., Fukatani M., et al. Relationship between atrial conduction defects and fractioned atrial endocardial electrocardiograms in patients with sick sinus syndrome. Pacing Clin Electrophysiol 2002; 16: 2022–3
   Google Scholar
• Papageoriou P., Monahan K., Boyle N. G., et al. Site dependent intra‐atrial conduction delay: Relationship to initiation of atrial fibrillation. Circulation 1996; 94: 348–9
   Web of Science ®Google Scholar
• Steinberg J. S., Zelenkofske S., Wong S. C., et al. Value of P‐wave signal‐averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993; 88: 2618–22
   PubMed Web of Science ®Google Scholar
• Vilani G. Q., Piepoli M., Cripps T., et al. Atrial late potentials in patients with paroxysmal atrial fibrillation detected using a high gain, signal‐averaged esophageal lead. Pacing Clin Electrophysiol 1994; 17: 1118–23
   PubMed Web of Science ®Google Scholar
• Klein M., Evans S. J. L., Cataldo L., et al. Use of P‐wave‐triggered, P‐wave signal‐averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 1995; 129: 895–901
   PubMed Web of Science ®Google Scholar
• Yamada T., Fukunami M., Shimonagata T., et al. Dispersion of signal‐averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J 1999; 20: 211–20
   PubMed Web of Science ®Google Scholar
• Aytemir K., Aksoyek S., Yıldırır A., et al. Prediction of atrial fibrillation recurrence after cardioversion by P wave signal‐averaged electrocardiography. Int J Cardiol 1999; 70: 15–21
   PubMed Web of Science ®Google Scholar
• Ozmen F., Atalar E., Aytemir K., et al. Effect of balloon‐induced acute ischemia on P wave dispersion during percutaneous transluminal coronary angioplasty. Europace 2001; 3: 299–303
   PubMed Web of Science ®Google Scholar
• Batur M. K., Yildirir A., Onalan O., Kabakci G., Tokgozoglu L., Oto A. Angioplasty induced myocardial ischaemia prolongs the signal‐averaged P‐wave duration in single vessel coronary artery disease. Europace 2002; 4: 289–93
   PubMed Web of Science ®Google Scholar
• Budeus M., Hennersdorf M., Dierkes S., et al. Effects of right coronary artery PTCA on variables of P‐wave signal averaged electrocardiogram. Ann Noninvasive Electrocardiol 2003; 8: 150–6
   PubMed Web of Science ®Google Scholar
• Akdemir R., Ozhan H., Gunduz H., et al. Effect of reperfusion on P‐wave duration and P‐wave dispersion in acute myocardial infarction: primary angioplasty versus thrombolytic therapy. Ann Noninvasive Electrocardiol 2005; 10: 35–40
   PubMed Web of Science ®Google Scholar
• Celik T., Iyisoy A., Kursaklioglu H., et al. Effects of primary percutaneous coronary intervention on P wave dispersion. Ann Noninvasive Electrocardiol 2005; 10: 342–7
   PubMed Web of Science ®Google Scholar
• Antman E. M., Anbe D. T., Armstrong P. W., et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588–636
   PubMed Web of Science ®Google Scholar
• Eldar M., Canetti M., Rotstein Z., Boyko V., et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 1998; 97: 965–70
   PubMed Web of Science ®Google Scholar
• The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118–23
   PubMed Web of Science ®Google Scholar
• Harjai K. J., Boura J., Grines L., et al. Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarction. Am J Cardiol 2002; 90: 1193–7
   PubMed Web of Science ®Google Scholar
• Bonnemeier H., Ortak J. Reperfusion associated cardioversion of atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electrocardiol 2005; 10: 224–5
   PubMed Web of Science ®Google Scholar
• Gorenek B., Birdane A., Unalir A., et al. Restoring sinus rhythm in patients with atrial fibrillation complicating acute myocardial infarction: comparison of outcomes of primary angioplasty and thrombolytic therapy. Eur J Heart Fail 2000, Suppl 1: 32, (abstract)
   Google Scholar
• Amiodarone Trials Meta‐Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta‐analysis of individual data from 6500 patients in randomised trials. Lancet 1997; 350: 1417–24
   PubMed Web of Science ®Google Scholar
• Wong C. K., White H. D., Wilcox R. G., et al. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO‐III experience. Heart 2002; 88: 357–62
   PubMed Web of Science ®Google Scholar
• Camm A. J., Pratt C. M., Schwartz P. J., et al. AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators. Mortality in patients after a recent myocardial infarction: a randomized, placebo‐controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004; 109: 990–6
   PubMed Web of Science ®Google Scholar